About CD Genomics

CD Genomics is committed to offering customers constant satisfaction by helping their life science research, pharmaceutical research and biotechnology, etc., and by discovering, developing, manufacturing and delivering innovative quality products and services. This approach begins by exploring techniques to unravel the complexities of life science and understand the fundamentals of human biology.

CD Genomics focuses on areas of biologics and chemicals with unparalleled manufacturing and analysis expertise to strive for solutions that improve research outcomes and dramatically improve the speed of success. As a biotechnology pioneer, CD Genomics has grown to be one of the world's largest independent biotechnology companies. We have reached millions of researchers and partners around the world and is developing more pipelines with breakaway potential.

We are simultaneously developing the most robust pipeline in our history. Headquartered in NY, our research operations are spread across multiple countries.

IT'S IN OUR NATURE TO BE BETTER.

Biotechnology and life science development are key innovation drivers for the move towards the Bio-based Economy. As a catalyst for innovation, CD Genomics is committed to having a positive impact on the sustainability of every household globally.

Our vision is to be recognized as a leading innovator of solutions that will empower the Bio-based Economy. We believe "Smarter Biotechnology" or the exquisite use of biotechnology for specific purposes will be a key driver in the creation of more sustainable findings.

Innovation and collaboration with like-minded organizations are already enabling us to integrate global resources into our business. These innovations also help address our global challenges in a new century. In our vision of the future, biotechnology fulfills many of society's unmet needs in the fields of food, health, energy, fuels and chemicals.